LTR PHARMA LIMITED ORDINARY (LTP) Short Interest
LTR PHARMA LIMITED ORDINARY (ASX:LTP) had 0.13% of shares reported as short positions as of 26 June 2026, representing 237,810 shares. LTR PHARMA LIMITED ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
LTP
Ltr Pharma
Pharmaceuticals, Biotechnology & Life Sciences
LTR Pharma is an Australian drug development company focused on men's health, specifically commercializing a rapid-onset, on-demand therapeutic nasal spray for erectile dysfunction. Their lead product, SPONTAN®, utilizes intranasal delivery technology of a PDE5 inhibitor, aiming for faster action and improved spontaneity compared to existing ED therapies.
pharmaceuticals
biotechnology
men's health
erectile dysfunction
Shorted
short percentage0.13%
reported shorts237.8K
shares on issue181.778M